COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

The Clinical, Integrative and Molecular Gastroenterology [CIMG] Study Section reviews applications concerned with molecular, integrative and clinically-oriented research related to the gastrointestinal (GI) system, including GI development and growth differentiation control, GI dysplasia and pre-neoplasia, brain-gut interactions, enteric nervous system, motility disorders, acid secretion and acid related disease, GI hormones, pancreatic function and dysfunction, GI system nutrient absorption, malabsorption/malnutrition, nutritional support, integrative GI physiology, genetic determinants of digestive diseases and GI system patient-oriented research.

The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Membership Panel

The membership panel is a list of chartered members only.


  • GI development and growth/differentiation control, GI stem cell biology, regulation of mechanisms of gene expression in the GI tract, GI dysplasia and pre-neoplasia, including mechanisms of transformation, immortalization, and mutagenesis.
  • GI motility, functional bowel disease, neurotransmitters and their actions, brain-gut interactions, enteric nervous system, GI hormones, mechanisms of visceral pain.
  • Acid secretion and acid-related disease including GERD, fluid and electrolyte transport, diarrhea and constipation.
  • Digestive system nutrient absorption and disposition, malabsorption/ malnutrition.
  • Exocrine pancreas function and dysfunction, therapy for genetic and acquired pancreatitis.
  • Integrative GI physiology: Studies ranging from normal physiology using animal/tissue models to mechanisms and consequences of disease.
  • Genetic determinants of digestive diseases, including increased risk of disorders of the digestive tract, inherited metabolic disorders, gene-gene interactions, genetic risk assessment, gene-environment interactions, structure/function analysis of disease-causing genes, and gene and somatic cell therapy.
  • Patient-oriented research. Studies of risk factors, etiology, detection, screening, modifying factors and therapy of GI diseases and disorders. Clinical, population and integrative studies of the responses of the digestive system to trauma or surgery, and digestive system ischemia/reperfusion injury.

Shared Interests and Overlaps

There are shared interests with the Gastrointestinal Mucosal Pathobiology (GMPB) study section including the role of the microbiome in GI physiology and pathophysiology, epithelial and stem cells. Studies focused on the mucosal layer or mucosal immunology are more appropriately assigned to GMPB.

There are shared interests with Integrative Nutrition and Metabolic Processes (INMP). Studies focused on transport mechanisms may be reviewed by CIMG while those emphasizing metabolic outcomes are best reviewed by INMP.